Tools

LEADER 01862cam 2200433 a 4500

001 ocn320245796;

003 OCoLC;

005 20090505122130.0;

006 m d f ;

007 cr b|||||a||||;

008 090505s2009 mdu ob f000 0 eng c;

040 a| GPOc| GPOd| MvI;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0499-T (online);

086 0 a| HE 20.4702:IN 3/DRAFT;

245 00 a| Guidance for industry :b| influenza, developing drugs for treatment and/or prophylaxis.;

246 30 a| Influenza, developing drugs for treatment and/or prophylaxis;

260 a| Silver Spring, MD :b| U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,c| [2009];

300 a| 27 p. :b| digital, PDF file;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

538 a| Mode of access: Internet from the CDER web site. Address as of 5/5/09: http://www.fda.gov/cder/guidance/7927dft.pdf; current access available via PURL.;

500 a| Title from title screen (viewed on May 5, 2009).;

500 a| "Draft guidance.";

500 a| "February 2009.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references (p. 26-27).;

650 0 a| Influenzax| Chemotherapyz| United States.=| ^A4722;

650 0 a| Influenza vaccinesx| Developmentz| United States.=| ^A610499;

650 0 a| Drug developmentz| United States.=| ^A443888;

710 2 a| Center for Drug Evaluation and Research (U.S.)=| ^A431016;

856 40 u| https://purl.fdlp.gov/GPO/LPS112225;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 1898831;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 1898831-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 9/14/2009x| EDOCUMENTz| JERESOURCEo| .STAFF. jlhb;

Guidance for industry : influenza, developing drugs for treatment and/or prophylaxis.

Other author	Center for Drug Evaluation and Research (U.S.)
Format	Electronic
Publication Info	Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
Description	27 p. : digital, PDF file
Supplemental Content	https://purl.fdlp.gov/GPO/LPS112225
Subjects	Influenza--Chemotherapy. --United States. Influenza vaccines--Development. --United States. Drug development--United States.

Portion of title	Influenza, developing drugs for treatment and/or prophylaxis
General note	Title from title screen (viewed on May 5, 2009).
General note	"Draft guidance."
General note	"February 2009."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references (p. 26-27).
Technical details	Mode of access: Internet from the CDER web site. Address as of 5/5/09: http://www.fda.gov/cder/guidance/7927dft.pdf; current access available via PURL.
GPO item number	0499-T (online)
Govt. docs number	HE 20.4702:IN 3/DRAFT

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Guidance for industry : influenza, developing drugs for treatment and/or prophylaxis.

Click here for more information about this title

Availability